RxDoctor Payments Data

Karen Goldie

Primary Care · Evansville, INNPI 1114552882

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $240 and has fallen 70.5% since, to $71 in 2025.

$494in general payments, 2019–2025

Across 31 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$83
  • Urovant Sciences Inc$67
  • AbbVie$52
  • Merz North America, Inc.$29
  • Boehringer Ingelheim$27
  • AstraZeneca$27
  • plus $209 from 13 others

What the payments were for

  • Food & beverage$494100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$494 in reported general payments places this provider in the 65th percentile of 113 primary care providers in Indiana.

See all primary care providers in Indiana

Medicare billing

Part B allowed, 2024
$8,438
Medicare patients
59
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amlodipine Besylate26$105
Atorvastatin Calcium14$67
Prednisone15$40

Paid to pharmacies, not to this prescriber.

Other primary care in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →